Highlights of the French Antimicrobial Resistance Surveillance Project

被引:9
作者
Pean, Y
Goldstein, FW
Guerrier, ML
机构
[1] HOP ST JOSEPH, CLIN MICROBIOL LAB, PARIS, FRANCE
[2] CHG, AIX EN PROVENCE, FRANCE
[3] CHU, AMIENS, FRANCE
[4] HOP HOTEL DIEU, ANGERS, FRANCE
[5] CHG R BALLINGER, AULNAY SOUS BOIS, FRANCE
[6] CH PELLEGRIN, BORDEAUX, FRANCE
[7] HOP COTE DE NACRE, CAEN, FRANCE
[8] CHU DU BOCAGE, DIJON, FRANCE
[9] CHU GRENOBLE, F-38043 GRENOBLE, FRANCE
[10] CHG, LAGNY, FRANCE
[11] CH LA CROIXROUSSE, LYON, FRANCE
[12] CH F QUESNAY, MANTES LA JOLIE, FRANCE
[13] CHG, MEAUX, FRANCE
[14] CH NOTRE DAME DU BON SECURS, METZ, FRANCE
[15] CH E MUELLER, MULHOUSE, FRANCE
[16] LAM BRIGNON THOMAS, NANCY, FRANCE
[17] CHU, NANCY, FRANCE
[18] CH, NANTERRE, FRANCE
[19] CHG, NEMOURS, FRANCE
[20] CH PASTEUR, NICE, FRANCE
[21] LAM RONCHESE DIESNIS, NICE, FRANCE
[22] HG, ORSAY, FRANCE
[23] CHU BICHAT, PARIS, FRANCE
[24] CH DU HAUT LEVEQUE, PESSAC, FRANCE
[25] CH J BERNARD, POITIERS, FRANCE
[26] CH R DEBRE, REIMS, FRANCE
[27] CHU PONTCHAILLOU, RENNES, FRANCE
[28] CH BELLEVUE, ST ETIENNE, FRANCE
[29] LAM DU PROGRES, ST ETIENNE, FRANCE
[30] CHG, ST GERMAIN EN LAYE, FRANCE
[31] CHU STRASBOURG, F-67000 STRASBOURG, FRANCE
[32] LAM DES CARMES, TOULOUSE, FRANCE
[33] LAM ARNAUD, TOURS, FRANCE
关键词
D O I
10.1016/S0732-8893(96)00137-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Thirty-three French laboratories took part in a study to deter mine the frequency of antibiotic resistance to S. pneumoniae, H. influenzae and M. catarrhalis in different regions of the country. A total of 1317 bacterial isolates were studied. The level of resistance to penicillin among isolates of S. pneumoniae was high particularly in children with otitis media or upper respiratory tract infections. In H. influenzae isolates the level of beta-lactamase production was over 30% in all groups of patients and specimen types and in M. catarrhalis the level of beta-lactamase production was in excess of 90%. Multidrug resistance was found often among the macrolides, tetracyclines, and trimethoprim/sulfamethoxazole, and these antimicrobials should not be regarded as therapeutic alternatives to the beta-lactams. (C) 1996 Elsevier Science Inc.
引用
收藏
页码:191 / 194
页数:4
相关论文
共 6 条
[1]  
*ANT COMM FRENCH S, 1994, PATHOL BIOL, V42, pR1
[2]   ANTIMICROBIAL SUSCEPTIBILITIES OF ISOLATES OF HAEMOPHILUS-INFLUENZAE, STRAINS ISOLATED IN FRANCE IN 1993 - REPORT OF THE CENTER-NATIONAL-DE-REFERENCE-POUR-H-INFLUENZAE [J].
DABERNAT, H .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 (12) :1244-1247
[3]   EPIDEMIOLOGY OF PNEUMOCOCCAL RESISTANCE TO ANTIBIOTICS IN FRANCE - NATIONAL COOPERATIVE SURVEY (1984-1993) [J].
GESLIN, P ;
FREMAUX, A ;
SISSIA, G ;
SPICQ, C ;
ABERRANE, S .
MEDECINE ET MALADIES INFECTIEUSES, 1994, 24 :948-961
[4]   Epidemiology of antibiotic resistance in Haemophilus influenzae [J].
Goldstein, FW ;
Acar, JF .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (02) :131-135
[5]  
GOLDSTEIN FW, 1996, 7 INT C INF DIS HONG
[6]  
Murray PR., 1995, MANUAL CLIN MICROBIO